NR 503 Week 5: Infectious Disease Paper Discussion

NR 503 Week 5: Infectious Disease Paper Discussion

NR 503 Week 5: Infectious Disease Paper Discussion – The Infectious Disease Paper assignment is due by Sunday, 11:59 p.m. MT at the end of Week 5. The assignment guidelines and grading rubric are located in the Course Resource section.

NR 503 Week 5: Infectious Disease Paper Discussion

Mycobacterium tuberculosis

Description of tuberculosis

Tuberculosis (TB) is a contagious, life-threatening infectious disease that primarily affects the lungs and is caused by the mycobacterium germ (Delogu, Sali, and Fadda, 2013). NR 503 Week 5: Infectious Disease Paper Discussion. General symptoms are a wracking cough, extreme weakness and fatigue, coughing up blood or phlegm (sputum), marked weight loss, fever and chills, profuse sweating, and severe chest pain while breathing or coughing (CDC: Signs and symptoms, 2016). A skin test or TB blood test are used to determine if a person has tuberculosis NR 503 Week 5: Infectious Disease Paper Discussion.

ORDER A PLAGIARISM-FREE PAPER HERE

The TB mode of transmission occurs when a person with TB coughs, sneezes, speaks, or opens his or her mouth; mycobacterium germs are released into the air and remain for hours— even days (CDC: How TB spreads, 2016). Complications of pulmonary TB include structural, metabolic, vascular, and infectious conditions (Shah & Reed, 2014). An acute complication of TB is sepsis (Shah & Reed, 2014). Chronic complications are pulmonary mycetoma or focal neurologic deficits from tuberculomas; pulmonary complications include hemoptysis (coughing up blood) or pneumothorax (collapsed lung) (Shah & Reed, 2014). TB is treated with or more first-line drugs for 6 to 12 months: isoniazid (INH), rifampin (RIF), ethambutol (EMB), and/or pyrazinamide (PZA) (CDC: Treatment for TB disease, 2016). If the strain of TB is resistant to first-line drugs, second-line group 2 drugs are given (CDC: Treatment for TB disease, 2016). Other TB drugs are categorized as second-line groups 3 and 4, and third-line group 5. The vaccine for TB is Bacille Calmette–Guèrin (BCG) (CDC: Treatment for TB disease, 2016). NR 503 Week 5: Infectious Disease Paper Discussion.

The NR 503 Week 5: Infectious Disease Paper Discussion assignment will follow the late assignment policy specified in the course syllabus.

NR 503 Week 5: Infectious Disease Paper Discussion

NR503 Week 5 Infectious Disease Grading Rubric, NR 503 Week 5: Infectious Disease Paper Discussion,
NR503 Week 5 Infectious Disease Grading Rubric
Criteria Ratings Pts

Introduction of Communicable Disease

NR 503 Week 5: Infectious Disease Paper Discussion

20.0 pts

Exceptional- Comprehensively describes the communicable disease (causes, symptoms, mode of transmission, complications, treatment) and the demographic of interest (mortality, morbidity, incidence, and prevalence).

18.0 pts

Exceeds- Adequately identifies the communicable disease (causes, symptoms, mode of transmission, complications, treatment) and the demographic of interest (mortality, morbidity, incidence, and prevalence).

16.0 pts

Meets- Limited description of the communicable disease (causes, symptoms, mode of transmission, complications, treatment) and the demographic of interest (mortality, morbidity, incidence, and prevalence).

8.0 pts

Needs Improvement- Unclear description of the communicable disease (causes, symptoms, mode of transmission, complications, treatment) and the demographic of interest (mortality, morbidity, incidence, and prevalence).

0.0 pts

Developing- Description of the communicable disease (causes, symptoms, mode of transmission, complications, treatment) and the demographic of interest (mortality, morbidity, incidence, and prevalence) is absent
20.0 pts

Determinants of Health

20.0 pts

Exceptional- Describe the determinants of health and explain how those factors contribute to the development of this disease. Evidence supports background.

18.0 pts

Exceeds- Determinants is complete, presents risk factors, disease impact and at least one set of incidence and prevalence statistics are presented and supported by evidence.

16.0 pts

Meets- Description of determinants is missing one or more key points. Limited presentation of the contributing factors. Lack of evidence to support.

8.0 pts

Needs Improvement- Determinants are missing more than one key point and lack of contributing factors. There is no supported evidence.

0.0 pts

Developing- Determinants and contributing factors of the disease is not provided.
20.0 pts

Host Factors

20.0 pts

Exceptional- Comprehensive review of the host factors, agent factors (presence or absence), and environmental factors.

18.0 pts

Exceeds- Adequate review of the host factors, agent factors (presence or absence), and environmental factors.

16.0 pts

Meets- Limited review of the host factors, agent factors (presence or absence), and environmental factors.

8.0 pts

Needs Improvement- Minimal or unclear review of the host factors, agent factors (presence or absence), and environmental factors.

0.0 pts

Developing- Review of the host factors, agent factors (presence or absence), and environmental factors not provided.
20.0 pts

Role of FNP

20.0 pts

Exceptional- A comprehensive review of the role of the community health FNP (case finding, reporting, data collecting, data analysis, and follow-up).

18.0 pts

Exceeds- An adequate, but not fully comprehensive, review of the role of the community health FNP (case finding, reporting, data collecting, data analysis, and follow-up).

16.0 pts

Meets- A limited review of the role of the community health FNP (case finding, reporting, data collecting, data analysis, and follow-up). The role is presented with limited or little evidence.

8.0 pts

Needs Improvement- The FNP role (case finding, reporting, data collecting, data analysis, and follow-up) is minimal or unclear and is not supported directly by evidence.

0.0 pts

Developing- The FNP role (case finding, reporting, data collecting, data analysis, and follow-up) is not provided.
20.0 pts

APA Format / Writing Mechanics

20.0 pts

Exceptional- APA format, grammar, spelling, and/or punctuation are accurate, or with zero to one errors.

18.0 pts

Exceeds- Two to four errors in APA format, grammar, spelling, and syntax noted.

16.0 pts

Meets- Five to seven errors in APA format, grammar, spelling, and syntax noted.

8.0 pts

Needs Improvement- Eight to nine errors in APA format, grammar, spelling, and syntax noted or the paper exceeds maximum of two (2) pages.

0.0 pts

Developing- Greater than ten errors in APA format, grammar, spelling, and/or punctuation noted or repeatedly makes the same errors after faculty feedback.
20.0 pts